Pant-treated D20 samples contained twofold more NK/ILC, CD4+ in the tumor and OVA-specific effector CD8+ T cells in the tumor-draining lymph nodes (TDLNs) (Fig 4B and C). This evidence concerns the gene CCL27 and neoplasm.